Non-hormonal therapy of post-menopausal vasomotor symptoms: A structured evidence-based review

被引：69
作者：
Cheema D. [1 ]
Coomarasamy A. [2 ]
El-Toukhy T. [2 ]
机构：
[1] Royal Worcestershire Hospital, Worcester
[2] Assisted Conception Unit, Guy's and St. Thomas Hospital, Thomas Guy House, SE1 9RT London, St Thomas Street
来源：
Archives of Gynecology and Obstetrics | 2007年 / 276卷 / 5期
关键词：
Complimentary; Herbal and alternative therapy; Hormone replacement therapy; Menopause; Non-hormonal; Vasomotor symptoms;
D O I：
10.1007/s00404-007-0390-9
中图分类号：
学科分类号：
摘要：
Background: Interest in non-hormonal therapies for the treatment of menopausal symptoms has increased since the publication of adverse effects of estrogen replacement therapy. Objective: To provide information on the efficacy of non-hormonal therapies for menopausal vasomotor symptoms based on evidence from published randomised controlled studies. Methods: The Cochrane Database of Systematic Reviews (CDSR), MEDLINE, Alternative Therapies in Health and Medicine database (ATHMD) and Allied and Complementary Medicine database (AMED) were searched for randomised controlled trials in the English language reporting data on treatment of menopausal vasomotor symptoms. Trials including cancer breast patients were included. Results: Our search identified 58 randomised controlled trials of which 11 involved the use of clonidine, six for SSRIs, four for gabapentin, seven for black cohosh, seven for red clover, 18 for phytoestrogens, two for ginseng, one for evening primrose, one for dong quai and one for vitamin E. Most trials had methodological deficiencies. Conclusion: There is evidence that clonidine, paroxetine, venlafaxine, gabapentin and black cohosh may be beneficial in the treatment of menopausal vasomotor symptoms in some women. Current evidence does not support the use of fluoxetine, red clover, phytoestrogens, Ginseng, evening primrose, dong quai and vitamin E. The side effects profile of these therapies should be considered. © 2007 Springer-Verlag.
引用
收藏
页码：463 / 469
页数：6
相关论文
共 71 条
[1]  
Bachmann G.A., Vasomotor flushes in menopausal women, Am J Obstet Gynecol, 180, (1999)
[2]  
Rossouw J.E., Anderson G.L., Prentice R.L., Lacroix A.Z., Kooperberg C., Stefanil M.L., Et al., Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized clinical trial, JAMA, 288, pp. 321-333, (2002)
[3]  
Beral V., Million Women Study Collaborators Breast cancer and hormone replacement therapy in the Million Women Study, Lancet, 362, pp. 419-427, (2003)
[4]  
Hersh A.L., Stefanik M.L., Stafford R.S., National use of postmenopausal hormone therapy, JAMA, 291, pp. 47-53, (2004)
[5]  
Lawton B., Rose, McLeod D., Dowell A., Changes in use of hormone replacement therapy after the report from Women's Health Initiative: Cross sectional survey of users, BMJ, 327, pp. 845-846, (2003)
[6]  
Nelson H.D., Vesco K.K., Haney E., Fu R., Nedrow A., Miller J., Nicolaides C., Walker M., Humphrey L., Nonhormonal therapies for menopausal hot flashes: Systematic review and meta-analysis, JAMA, 295, pp. 2057-2071, (2006)
[7]  
Goldberg R.M., Loprinzi C.L., O'Fallon J.R., Et al., Transdermal clonidine for ameliorating tamoxifen-induced hot flashes, Clin Oncol, 12, pp. 155-158, (1994)
[8]  
Pandya K.J., Raubertas R.F., Flynn P.J., Et al., Oral clonidine in postmenopausal patients with breast cancer experiencing tamoxifen induced hot flashes: A University of Rochester Cancer Center Community Clinical Oncology Program study, Ann Intern Med, 132, pp. 788-793, (2002)
[9]  
Edington R.F., Chagnon, Clonidine (Dixarit) for menopausal flushing, Can Med Assoc J, 123, pp. 23-26, (1980)
[10]  
Nagamani M., Kelver M.E., Smith E.R., Treatment of menopausal hot flashes with transdermal administration of clonidine, Am J Obstet Gynecol, 156, pp. 561-565, (1987)
12345678